**
Overview
Mitochondrial Myopathies (MM) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is responsible for producing energy for the cell. Mitochondrial Myopathies can affect various parts of the body, including the muscles, nervous system, and other organs. The symptoms of MM can vary widely, depending on the specific type of disorder and the individual affected. Common symptoms include muscle weakness, fatigue, and pain, as well as problems with vision, hearing, and balance.
Mitochondrial Myopathies are often inherited in an autosomal dominant or maternal pattern, meaning that a single copy of the mutated gene is enough to cause the disorder. In some cases, the disorder can be caused by a new mutation, rather than an inherited one. Diagnosis of MM typically involves a combination of genetic testing, muscle biopsy, and other medical tests. Treatment for MM is often focused on managing symptoms and improving quality of life, as there is currently no cure for the disorder.
History/Background
The first descriptions of Mitochondrial Myopathies date back to the 1960s, when researchers began to identify the role of mitochondria in energy production. However, it wasn't until the 1980s that the genetic basis of MM was discovered. In 1988, a team of researchers identified the first mitochondrial DNA mutation associated with a myopathic disorder. Since then, numerous other mutations have been identified, and our understanding of the genetic basis of MM has continued to grow.
Key Information
Mitochondrial Myopathies are a heterogeneous group of disorders, with over 150 different mutations identified to date. The most common types of MM include:
* Kearns-Sayre Syndrome: a rare disorder characterized by progressive external ophthalmoplegia (PEO), muscle weakness, and cardiac conduction abnormalities.
* Myoclonic Epilepsy with Ragged-Red Fibers (MERRF): a disorder characterized by myoclonic seizures, muscle weakness, and ragged-red fibers on muscle biopsy.
* NARP Syndrome: a disorder characterized by neuropathy, ataxia, and retinitis pigmentosa.
Significance
Mitochondrial Myopathies are a significant public health concern, affecting an estimated 1 in 5,000 people worldwide. While the disorders are rare, they can have a profound impact on the quality of life for those affected. Research into MM has also led to a greater understanding of the role of mitochondria in energy production and the development of new treatments for other disorders.
INFOBOX:
- Name: Mitochondrial Myopathies
- Type: Genetic disorder
- Date: 1960s (first descriptions), 1988 (identification of first mitochondrial DNA mutation)
- Location: Worldwide
- Known For: Rare genetic disorders affecting the mitochondria
TAGS: Mitochondrial Myopathies, Genetic Disorders, Rare Diseases, Mitochondrial DNA, Energy Production, Muscle Weakness, Fatigue, Pain, Vision Problems, Hearing Loss, Balance Disorders, Autosomal Dominant Inheritance, Maternal Inheritance, New Mutation, Genetic Testing, Muscle Biopsy, Symptom Management, Quality of Life.
